Sangamo Therapeutics, Inc.
Methods and compositions for treating hemophilia

Last updated:

Abstract:

Disclosed herein are methods and compositions for insertion of transgene sequences encoding proteins involved in clotting into the genome of a cell for treating conditions including hemophilias.

Status:
Grant
Type:

Utility

Filling date:

9 Aug 2017

Issue date:

10 Sep 2019